Comparison Chart Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VERTEX PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	-1.34%	-1.73%	+3.83%	+1.86%	+135.30%	119B

Market Closed - Nasdaq Other stock markets 06:00:00 04/08/26 am AEST			Pre-market 09:24:06 pm
470.72 ^USD	-1.34%		453.03	-3.76%

08:56pm	Barclays Adjusts PT on Vertex Pharmaceuticals to $617 From $615, Maintains Overweight Rating	MT
08:36pm	Goldman Sachs Adjusts PT on Vertex Pharmaceuticals to $653 From $652, Maintains Buy Rating	MT

Comparison Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Compared values